The use of hydroxycarbamide in children with sickle cell anemia
Background: Although hydroxycarbamide (hydroxyurea [HU]) has been in use for decades in both adults and child populations with sickle cell disease (SCD), its reported use has remained low in Africa and Nigeria where the largest number of SCD patients reside. Availability, cost, and concerns about sa...
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Seri Bilgileri: | Sahel Medical Journal |
| Konular: | |
| Online Erişim: | http://www.smjonline.org/article.asp?issn=1118-8561;year=2018;volume=21;issue=4;spage=189;epage=193;aulast=Ahmad |